Cumberland Pharmaceuticals (CPIX) Receivables: 2009-2025
Historic Receivables for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $10.4 million.
- Cumberland Pharmaceuticals' Receivables fell 7.78% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year decrease of 0.92%. This contributed to the annual value of $11.7 million for FY2024, which is 19.91% up from last year.
- Cumberland Pharmaceuticals' Receivables amounted to $10.4 million in Q3 2025, which was up 1.10% from $10.3 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Receivables ranged from a high of $15.2 million in Q3 2022 and a low of $6.9 million during Q4 2021.
- Its 3-year average for Receivables is $11.4 million, with a median of $11.3 million in 2024.
- The largest annual percentage gain for Cumberland Pharmaceuticals' Receivables in the last 5 years was 110.92% (2021), contrasted with its biggest fall of 44.44% (2021).
- Cumberland Pharmaceuticals' Receivables (Quarterly) stood at $6.9 million in 2021, then soared by 91.41% to $13.2 million in 2022, then declined by 25.87% to $9.8 million in 2023, then climbed by 19.91% to $11.7 million in 2024, then declined by 7.78% to $10.4 million in 2025.
- Its last three reported values are $10.4 million in Q3 2025, $10.3 million for Q2 2025, and $10.5 million during Q1 2025.